# Phase One Ventures

> Phase One Ventures is a VC fund in Glendale backing Medical and Software. See 6 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Glendale, United States
- Total investments: 6
- Last investment: Feb 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/phase1ventures
- X (Twitter): https://twitter.com/Phaseoneventure
- Website: https://www.phaseoneventures.com/
- Facebook: https://www.facebook.com/phase1ventures

Phase One Ventures is a VC fund in Glendale focused on Medical and Software. Phase One Ventures, LLC is a venture fund designed to manage Phase One Ventures Limited Partner Fund, LLP. The fund invests in technologies at the intersection of biotechnology and nanotechnology to create successful companies with the help of our experienced team.There is an abundance of both State and private capital available in New Mexicoto invest in innovation and technology based entrepreneurial companies. Phase One Ventures LLC believes that higher returns on investment and improved success rates can be achieved by taken a decidedly different, highly focused approach to the market. Key Elements of this strategy for success are shown at the right.

## Contacts

5 contacts available for Phase One Ventures. Shizune tracks 4 team members at Phase One Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/phase-one-ventures-5ebb?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 17% |
| Software | 1 | 17% |
| Compliance | 1 | 17% |
| Legal Tech | 1 | 17% |
| Health Care | 1 | 17% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 33% |
| Pre-Seed | 2 | 33% |
| Series A | 2 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chuck Call | PARTNERS | 0 | https://shizune.co/investors/profile/chuck-call |
| John Chavez | PARTNERS | 0 | https://shizune.co/investors/profile/john-chavez |
| John Elling | PARTNERS | 0 | https://shizune.co/investors/profile/john-elling |
| Rick Sanders | General Partner | 0 | https://shizune.co/investors/profile/rick-sanders |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ivo | Ivo provides an AI-powered contract intelligence platform that helps legal and business teams review, analyze, and extract insights from agreements. It offers tools for automated redlining and comparison against playbooks, a repository that organizes contract libraries without manual tagging, and an assistant that answers complex contract questionsusing natural language. The platform connects to common workflows like Microsoft Word and enables users to uncover relationships between contract documents and surface risk or deviation patterns. Ivo’s technology aims to reduce the manual effort in contract review and support strategic decision-making across functions that work with agreements. | $16M | Series A | Feb 05, 2025 | https://www.latchapp.com/ |
| Ivo | Ivo provides an AI-powered contract intelligence platform that helps legal and business teams review, analyze, and extract insights from agreements. It offers tools for automated redlining and comparison against playbooks, a repository that organizes contract libraries without manual tagging, and an assistant that answers complex contract questionsusing natural language. The platform connects to common workflows like Microsoft Word and enables users to uncover relationships between contract documents and surface risk or deviation patterns. Ivo’s technology aims to reduce the manual effort in contract review and support strategic decision-making across functions that work with agreements. | $4.8M | Seed | Apr 04, 2024 | https://www.latchapp.com/ |
| Prana Thoracic | Houston-based medical device startup Prana Thoracic, Inc. is dedicated to developing solutions for early intervention in lung cancer. We are an experienced team of surgeons, engineers and entrepreneurs on a mission to tackle lung cancer; the #1 cancer killer in the US.The paradigm of screening, detection, and early intervention that has beendeployed in other major cancers has so far eluded lung cancer. As a result, only 16% of lung cancers are found at an early stage and the current 5-year survival rate is < 20%. Recent changes to lung cancer screening guidelines have illuminated a path to improving outcomes in lung cancer. However, these advances rely on excising suspicious nodules and providing sufficient tissue for definitive diagnosis. We believe this is the missing piece of the puzzle, and physicians need a new generation of surgical oncology tools for lung cancer.Prana Thoracic plans to revolutionize the early diagnosis and treatment of lung cancer by making it easier and less invasive to deal with the rapidly growing number of early suspicious lung nodules; ensuring that we do not miss the window of opportunity to intervene early. | $3M | Series A | Oct 19, 2022 | https://www.pranathoracic.com/ |
| Ivo | Ivo provides an AI-powered contract intelligence platform that helps legal and business teams review, analyze, and extract insights from agreements. It offers tools for automated redlining and comparison against playbooks, a repository that organizes contract libraries without manual tagging, and an assistant that answers complex contract questionsusing natural language. The platform connects to common workflows like Microsoft Word and enables users to uncover relationships between contract documents and surface risk or deviation patterns. Ivo’s technology aims to reduce the manual effort in contract review and support strategic decision-making across functions that work with agreements. | $1.4M | Pre-Seed | Sep 16, 2022 | https://www.latchapp.com/ |
| Parabeac | Parabeac helps app development teams automate their design to development process for UI/UX. | $685K | Seed | Nov 02, 2021 | http://parabeac.com |
| Recensa Therapeutics | Recensa is developing small molecules that activate the transcription factor Nrf2, a key modulator of antioxidant response. These molecules will be embedded in topical vehicles-such as creams or lotions-and will be tested in animal models of psoriasis so we can gain FDA approval for human clinical trials. Future products may target other diseaseswhere oxidative stress is a key factor | $27K | Pre-Seed | Jun 16, 2016 | https://www.recensatherapeutics.com/ |

6 of 6 investments shown.

## Co-investors
- [GD1 (Global From Day One)](https://shizune.co/investors/profile/global-from-day-one-fund-ii) — VC Fund, 4 deals together
- [Fika Ventures](https://shizune.co/investors/profile/fika-ventures) — VC Fund, 2 deals together
- [Uncork Capital](https://shizune.co/investors/profile/softtech-vc) — VC Fund, 2 deals together
- [Abstraction Capital](https://shizune.co/investors/profile/abstraction-capital) — VC Fund, 1 deal together
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund, 1 deal together
- [Central Texas Angel Network](https://shizune.co/investors/profile/central-texas-angel-network) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund
- [The LegalTech Fund](https://shizune.co/investors/profile/the-legaltech-fund) — VC Fund
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Legal VC Funds in United States](https://shizune.co/investors/legal-vc-funds-united-states)

## FAQ

### What does Phase One Ventures invest in?

Phase One Ventures invests primarily in Medical, Software and Compliance startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Phase One Ventures?

Public channels for Phase One Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Phase One Ventures?

The team at Phase One Ventures includes Chuck Call (PARTNERS), John Chavez (PARTNERS) and John Elling (PARTNERS). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co